1. Home
  2. RDY vs NZF Comparison

RDY vs NZF Comparison

Compare RDY & NZF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • NZF
  • Stock Information
  • Founded
  • RDY 1984
  • NZF 2001
  • Country
  • RDY India
  • NZF United States
  • Employees
  • RDY N/A
  • NZF N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • NZF Finance Companies
  • Sector
  • RDY Health Care
  • NZF Finance
  • Exchange
  • RDY Nasdaq
  • NZF Nasdaq
  • Market Cap
  • RDY 2.1B
  • NZF 2.3B
  • IPO Year
  • RDY N/A
  • NZF N/A
  • Fundamental
  • Price
  • RDY $14.53
  • NZF $11.94
  • Analyst Decision
  • RDY Strong Buy
  • NZF
  • Analyst Count
  • RDY 2
  • NZF 0
  • Target Price
  • RDY $16.95
  • NZF N/A
  • AVG Volume (30 Days)
  • RDY 1.5M
  • NZF 496.8K
  • Earning Date
  • RDY 07-28-2025
  • NZF 01-01-0001
  • Dividend Yield
  • RDY 0.56%
  • NZF 4.67%
  • EPS Growth
  • RDY 1.47
  • NZF N/A
  • EPS
  • RDY 0.79
  • NZF N/A
  • Revenue
  • RDY $3,809,801,863.00
  • NZF N/A
  • Revenue This Year
  • RDY $10.24
  • NZF N/A
  • Revenue Next Year
  • RDY N/A
  • NZF N/A
  • P/E Ratio
  • RDY $18.39
  • NZF N/A
  • Revenue Growth
  • RDY 16.61
  • NZF N/A
  • 52 Week Low
  • RDY $12.26
  • NZF $9.82
  • 52 Week High
  • RDY $16.89
  • NZF $12.29
  • Technical
  • Relative Strength Index (RSI)
  • RDY 37.98
  • NZF 52.31
  • Support Level
  • RDY $14.81
  • NZF $11.72
  • Resistance Level
  • RDY $15.25
  • NZF $12.02
  • Average True Range (ATR)
  • RDY 0.20
  • NZF 0.06
  • MACD
  • RDY -0.12
  • NZF 0.01
  • Stochastic Oscillator
  • RDY 5.18
  • NZF 66.07

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About NZF Nuveen Municipal Credit Income Fund

Nuveen Municipal Credit Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and to enhance portfolio value relative to the municipal bond market by investing in an actively managed portfolio of tax-exempt municipal securities.

Share on Social Networks: